Search Results - "Mulcahy, Mary"

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma by Salem, Riad, Gordon, Andrew C, Mouli, Samdeep, Hickey, Ryan, Kallini, Joseph, Gabr, Ahmed, Mulcahy, Mary F, Baker, Talia, Abecassis, Michael, Miller, Frank, Yaghmai, Vahid, Sato, Kent, Desai, Kush, Thornburg, Bartley, Benson, Al B, Rademaker, Alfred, Ganger, Daniel, Kulik, Laura, Lewandowski, Robert J

“…Background & Aims Conventional transarterial chemoembolization (cTACE) is used to treat patients with hepatocellular carcinoma (HCC). Radioembolization is a…”
Get full text

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study by Kamath, Suneel D., Kalyan, Aparna, Kircher, Sheetal, Nimeiri, Halla, Fought, Angela J., Benson, Al, Mulcahy, Mary

“…Background Pancreatic ductal adenocarcinoma (PDAC) remains resistant to chemotherapy and immunotherapy individually because of its desmoplastic stroma and…”
Get full text

Evolution of therapy for locally advanced rectal cancer by Altomare, Nicole J., Mulcahy, Mary F.

“…Rectal cancer is a prevalent disease worldwide. The standard treatment of locally advanced rectal cancer (LARC) is preoperative chemoradiotherapy followed by…”
Get full text

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) by LEE KINDLER, Hedy, NIEDZWIECKI, Donna, PICUS, Joel, BHARGAVA, Pankaj, MAYER, Robert J, SCHILSKY, Richard L, GOLDBERG, Richard M, HOLLIS, Donna, SUTHERLAND, Susan, SCHRAG, Deborah, HURWITZ, Herbert, INNOCENTI, Federico, FRANCES MULCAHY, Mary, O'REILLY, Eileen, WOZNIAK, Timothy F

“…The combination of gemcitabine plus bevacizumab produced a 21% response rate and a median survival of 8.8 months in a multicenter phase II trial in patients…”
Get full text

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience by Salem, Riad, Gabr, Ahmed, Riaz, Ahsun, Mora, Ronald, Ali, Rehan, Abecassis, Michael, Hickey, Ryan, Kulik, Laura, Ganger, Daniel, Flamm, Steven, Atassi, Rohi, Atassi, Bassel, Sato, Kent, Benson, Al B., Mulcahy, Mary F., Abouchaleh, Nadine, Asadi, Ali Al, Desai, Kush, Thornburg, Bartley, Vouche, Michael, Habib, Ali, Caicedo, Juan, Miller, Frank H., Yaghmai, Vahid, Kallini, Joseph R., Mouli, Samdeep, Lewandowski, Robert J.

“…Yttrium‐90 transarterial radioembolization (TARE) is a locoregional therapy (LRT) for hepatocellular carcinoma (HCC). In this study, we present overall…”
Get full text

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes by Salem, Riad, Lewandowski, Robert J, Mulcahy, Mary F, Riaz, Ahsun, Ryu, Robert K, Ibrahim, Saad, Atassi, Bassel, Baker, Talia, Gates, Vanessa, Miller, Frank H, Sato, Kent T, Wang, Ed, Gupta, Ramona, Benson, Al B, Newman, Steven B, Omary, Reed A, Abecassis, Michael, Kulik, Laura

“…Background & Aims Hepatocellular carcinoma (HCC) has limited treatment options; long-term outcomes following intra-arterial radiation are unknown. We assessed…”
Get full text

Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis by Mouli, Samdeep, MD, Memon, Khairuddin, MD, Baker, Talia, MD, Benson, Al B., MD, Mulcahy, Mary F., MD, Gupta, Ramona, MD, Ryu, Robert K., MD, Salem, Riad, MD, Lewandowski, Robert J., MD

“…Abstract Purpose To present data on safety, antitumoral response, and survival following yttrium-90 (90 Y) radioembolization for patients with unresectable…”
Get full text

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial by Mulcahy, Mary F, Mahvash, Armeen, Pracht, Marc, Montazeri, Amir H, Bandula, Steve, Martin, 2nd, Robert C G, Herrmann, Ken, Brown, Ewan, Zuckerman, Darryl, Wilson, Gregory, Kim, Tae-You, Weaver, Andrew, Ross, Paul, Harris, William P, Graham, Janet, Mills, Jamie, Yubero Esteban, Alfonso, Johnson, Matthew S, Sofocleous, Constantinos T, Padia, Siddharth A, Lewandowski, Robert J, Garin, Etienne, Sinclair, Philip, Salem, Riad

“…To study the impact of transarterial Yttrium-90 radioembolization (TARE) in combination with second-line systemic chemotherapy for colorectal liver metastases…”
Get full text

Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection by Vouche, Michael, Lewandowski, Robert J, Atassi, Rohi, Memon, Khairuddin, Gates, Vanessa L, Ryu, Robert K, Gaba, Ron C, Mulcahy, Mary F, Baker, Talia, Sato, Kent, Hickey, Ryan, Ganger, Daniel, Riaz, Ahsun, Fryer, Jonathan, Caicedo, Juan Carlos, Abecassis, Michael, Kulik, Laura, Salem, Riad

“…Background & Aims Portal vein embolization (PVE) is a standard technique for patients not amenable to liver resection due to small future liver remnant ratio…”
Get full text

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization by Salem, Riad, Gilbertsen, Margaret, Butt, Zeeshan, Memon, Khairuddin, Vouche, Michael, Hickey, Ryan, Baker, Talia, Abecassis, Michael M, Atassi, Rohi, Riaz, Ahsun, Cella, David, Burns, James L, Ganger, Daniel, Benson, Al B, Mulcahy, Mary F, Kulik, Laura, Lewandowski, Robert

“…Background & Aims Quality of life (QoL) is an important aspect of any palliative treatment. However, few data are available from studies comparing how…”
Get full text

Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma by Salem, Riad, Lewandowski, Robert J, Kulik, Laura, Wang, Edward, Riaz, Ahsun, Ryu, Robert K, Sato, Kent T, Gupta, Ramona, Nikolaidis, Paul, Miller, Frank H, Yaghmai, Vahid, Ibrahim, Saad M, Senthilnathan, Seanthan, Baker, Talia, Gates, Vanessa L, Atassi, Bassel, Newman, Steven, Memon, Khairuddin, Chen, Richard, Vogelzang, Robert L, Nemcek, Albert A, Resnick, Scott A, Chrisman, Howard B, Carr, James, Omary, Reed A, Abecassis, Michael, Benson, Al B, Mulcahy, Mary F

“…Background & Aims Chemoembolization is one of several standards of care treatment for hepatocellular carcinoma (HCC). Radioembolization with Yttrium-90…”
Get full text

Complications Following Radioembolization with Yttrium-90 Microspheres: A Comprehensive Literature Review by Riaz, Ahsun, MD, Lewandowski, Robert J., MD, Kulik, Laura M., MD, Mulcahy, Mary F., MD, Sato, Kent T., MD, Ryu, Robert K., MD, Omary, Reed A., MD, MS, Salem, Riad, MD, MBA

“…The past decade has seen significant advancement in the locoregional management of liver tumors; novel and promising therapies such as transarterial…”
Get full text

Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization by Riaz, Ahsun, M.D, Gates, Vanessa L., M.S, Atassi, Bassel, M.D, Lewandowski, Robert J., M.D, Mulcahy, Mary F., M.D, Ryu, Robert K., M.D, Sato, Kent T., M.D, Baker, Talia, M.D, Kulik, Laura, M.D, Gupta, Ramona, M.D, Abecassis, Michael, M.D, Benson, Al B., M.D, Omary, Reed, M.D, Millender, Laura, M.D, Kennedy, Andrew, M.D, Salem, Riad, M.D

“…Purpose To describe a technique of segmental radioembolization for the treatment of patients with unresectable hepatocellular carcinoma (HCC). Radiation…”
Get full text

A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer by BERLIN, Jordan, BENDELL, Johanna C, GRAHAM, Richard A, BRAY, Gordon L, LOW, Jennifer A, HART, Lowell L, FIRDAUS, Irfan, GORE, Ira, HERMANN, Robert C, MULCAHY, Mary F, ZALUPSKI, Mark M, MACKEY, Howard M, YAUCH, Robert L

“…Vismodegib, a Hedgehog pathway inhibitor, has preclinical activity in colorectal cancer (CRC) models. This trial assessed the efficacy, safety, and…”
Get full text

Effect of Postoperative Complications on Adjuvant Chemotherapy Use for Stage III Colon Cancer by Merkow, Ryan P, Bentrem, David J, Mulcahy, Mary F, Chung, Jeanette W, Abbott, Daniel E, Kmiecik, Thomas E, Stewart, Andrew K, Winchester, David P, Ko, Clifford Y, Bilimoria, Karl Y

“…OBJECTIVE:The National Quality Forum has endorsed a quality metric concerning the use of adjuvant chemotherapy administration in stage III colon cancer, yet a…”
Get full text

Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study by Hardacre, Jeffrey M., Mulcahy, Mary, Small, William, Talamonti, Mark, Obel, Jennifer, Krishnamurthi, Smitha, Rocha-Lima, Caio S., Safran, Howard, Lenz, Heinz-Joseph, Chiorean, E. Gabriela

“…Background Despite continued investigation, limited progress has been made in the adjuvant treatment of resected pancreatic cancer. Novel or targeted therapies…”
Get full text

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines by Ajani, Jaffer A, Bentrem, David J, Besh, Stephen, D'Amico, Thomas A, Das, Prajnan, Denlinger, Crystal, Fakih, Marwan G, Fuchs, Charles S, Gerdes, Hans, Glasgow, Robert E, Hayman, James A, Hofstetter, Wayne L, Ilson, David H, Keswani, Rajesh N, Kleinberg, Lawrence R, Korn, W Michael, Lockhart, A Craig, Meredith, Kenneth, Mulcahy, Mary F, Orringer, Mark B, Posey, James A, Sasson, Aaron R, Scott, Walter J, Strong, Vivian E, Varghese, Jr, Thomas K, Warren, Graham, Washington, Mary Kay, Willett, Christopher, Wright, Cameron D, McMillian, Nicole R, Sundar, Hema

“…The NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer provide evidence- and consensus-based recommendations for a multidisciplinary approach for…”
Get more information

Prospective randomized pilot study of Y90 +/− sorafenib as bridge to transplantation in hepatocellular carcinoma by Kulik, Laura, Vouche, Michael, Koppe, Sean, Lewandowski, Robert J, Mulcahy, Mary F, Ganger, Daniel, Habib, Ali, Karp, Jennifer, Al-Saden, Patrice, Lacouture, Mario, Cotliar, Jonathan, Abecassis, Michael, Baker, Talia, Salem, Riad

“…Background & Aims To investigate the safety and adverse event profile of sorafenib plus radioembolization (Y90) compared to Y90 alone in patients awaiting…”
Get full text

Esophageal and esophagogastric junction cancers, version 1.2015 by Ajani, Jaffer A, D'Amico, Thomas A, Almhanna, Khaldoun, Bentrem, David J, Besh, Stephen, Chao, Joseph, Das, Prajnan, Denlinger, Crystal, Fanta, Paul, Fuchs, Charles S, Gerdes, Hans, Glasgow, Robert E, Hayman, James A, Hochwald, Steven, Hofstetter, Wayne L, Ilson, David H, Jaroszewski, Dawn, Jasperson, Kory, Keswani, Rajesh N, Kleinberg, Lawrence R, Korn, W Michael, Leong, Stephen, Lockhart, A Craig, Mulcahy, Mary F, Orringer, Mark B, Posey, James A, Poultsides, George A, Sasson, Aaron R, Scott, Walter J, Strong, Vivian E, Varghese, Jr, Thomas K, Washington, Mary Kay, Willett, Christopher G, Wright, Cameron D, Zelman, Debra, McMillian, Nicole, Sundar, Hema

“…Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Adenocarcinoma is more common in North America and Western European countries,…”
Get more information

Radioembolization for Neuroendocrine Liver Metastases: Safety, Imaging, and Long-Term Outcomes by Memon, Khairuddin, M.D, Lewandowski, Robert J., M.D, Mulcahy, Mary F., M.D, Riaz, Ahsun, M.D, Ryu, Robert K., M.D, Sato, Kent T., M.D, Gupta, Ramona, M.D, Nikolaidis, Paul, M.D, Miller, Frank H., M.D, Yaghmai, Vahid, M.D, Gates, Vanessa L., M.S, Atassi, Bassel, M.D, Newman, Steven, M.D, Omary, Reed A., M.D, Benson, Al B., M.D, Salem, Riad, M.D., M.B.A

“…Purpose To present long-term outcomes on the safety and efficacy of Yttrium-90 radioembolization in the treatment of unresectable hepatic neuroendocrine…”
Get full text